On International Day of Education, January 24, FIP will host a digital event to launch the handbook "Promoting research and postgraduate education in pharmacy and pharmaceutical sciences." This handbook highlights the crucial role of advanced education and research in driving developments in pharmacy and pharmaceutical sciences. The event will outline practical strategies for enhancing postgraduate enrolment, boosting research impact, and broadening career pathways within the field. Participants will learn about successful, tested initiatives that have been implemented at FIP AIM schools worldwide, aimed at strengthening their research and educational competencies.

Moderator:

- Pierre Moreau, Executive Director, Association of Faculties of Pharmacy of Canada (AFPC), Canada

Facilitator:

- Ozge Ozer, FIP Education and Professional Development Manager, FIP, The Netherlands

Guests:

- John A. Pieper, Professor and President Emeritus, University of Health Sciences & Pharmacy in St. Louis, USA

- Lilian M. Azzopardi, Professor, Department of Pharmacy at the Faculty of Medicine and Surgery of the University of Malta, Malta

- Sherief Khalifa, Vice Chancellor Academic Affairs & Dean, College of Pharmacy, Dubai Pharmacy College - Dubai Medical University, United Arab Emirates

- Nsovo Mayimele, Lecturer, Tshwane University of Technology, South Africa

- Renukha Sellappans, Head of School, School of Pharmacy, Taylor’s University, Malaysia

- Wafa Al Madhagi, Prof. Assistant, Sana'a University, Yemen - Indre Treciokiene, Assoc. Prof., Vilnius University, Lithuania

3D drug printing is an additive manufacturing technique for producing customized medications. This innovative technology enables precise control over drug dosage, shape, size, and release profile, facilitating personalized treatments for patients. It allows the creation of complex drug geometries that traditional methods cannot achieve. Key applications include personalized medicine, rapid prototyping of drug formulations, and polypharmacy production. By improving therapeutic outcomes, minimizing side effects, and transforming pharmaceutical manufacturing, 3D drug printing shows immense potential. This webinar offers an introduction to the technology, explores its regulatory landscape, and discusses how AI can further advance its development and applications.

Co-Chairs:

- Fereshteh Shokri, Senior Industry Pharmacist specialist at 3D drug printing technology, International Pharmaceutical Federation (FIP), The Netherlands

- Simon Gaisford, Professor of Pharmaceutics, University College London - Pharmaceutics, United Kingdom

Panellist:

- Anna Worsley, Director of Innovation at FABRX, CEO of the FABRX-AI, United Kingdom